Mercator MedSystems, Inc.
10 clinical trials · Sponsor
◉ Watch Mercator MedSystems, Inc.
| Record | Firm | Date |
|---|---|---|
| Temsirolimus Adventitial Delivery to Improve ANGioplasty and/or Atherectomy Revascularization Outcomes Below the Knee (NCT04433572) | Mercator MedSystems, Inc. | 2025-07-30 |
| Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Subacute and Chronic Iliofemoral DVT (NCT04858776) | Mercator MedSystems, Inc. | 2022-08-08 |
| Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Acute Femoropopliteal DVT (NCT04862468) | Mercator MedSystems, Inc. | 2021-10-29 |
| Temsirolimus Alone or Paired With Dexamethasone Delivered to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization (NCT03942601) | Mercator MedSystems, Inc. | 2019-10-01 |
Track Mercator MedSystems, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.